343 related articles for article (PubMed ID: 28597072)
1. Normal and altered pre-mRNA processing in the DMD gene.
Tuffery-Giraud S; Miro J; Koenig M; Claustres M
Hum Genet; 2017 Sep; 136(9):1155-1172. PubMed ID: 28597072
[TBL] [Abstract][Full Text] [Related]
2. Non-sequential and multi-step splicing of the dystrophin transcript.
Gazzoli I; Pulyakhina I; Verwey NE; Ariyurek Y; Laros JF; 't Hoen PA; Aartsma-Rus A
RNA Biol; 2016; 13(3):290-305. PubMed ID: 26670121
[TBL] [Abstract][Full Text] [Related]
3. Endogenous Multiple Exon Skipping and Back-Splicing at the DMD Mutation Hotspot.
Suzuki H; Aoki Y; Kameyama T; Saito T; Masuda S; Tanihata J; Nagata T; Mayeda A; Takeda S; Tsukahara T
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754374
[TBL] [Abstract][Full Text] [Related]
4. Nested introns in an intron: evidence of multi-step splicing in a large intron of the human dystrophin pre-mRNA.
Suzuki H; Kameyama T; Ohe K; Tsukahara T; Mayeda A
FEBS Lett; 2013 Mar; 587(6):555-61. PubMed ID: 23395799
[TBL] [Abstract][Full Text] [Related]
5. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.
Gurvich OL; Tuohy TM; Howard MT; Finkel RS; Medne L; Anderson CB; Weiss RB; Wilton SD; Flanigan KM
Ann Neurol; 2008 Jan; 63(1):81-9. PubMed ID: 18059005
[TBL] [Abstract][Full Text] [Related]
6. Modulation of in vitro splicing of the upstream intron by modifying an intra-exon sequence which is deleted from the dystrophin gene in dystrophin Kobe.
Takeshima Y; Nishio H; Sakamoto H; Nakamura H; Matsuo M
J Clin Invest; 1995 Feb; 95(2):515-20. PubMed ID: 7860733
[TBL] [Abstract][Full Text] [Related]
7. Tissue- and case-specific retention of intron 40 in mature dystrophin mRNA.
Nishida A; Minegishi M; Takeuchi A; Niba ET; Awano H; Lee T; Iijima K; Takeshima Y; Matsuo M
J Hum Genet; 2015 Jun; 60(6):327-33. PubMed ID: 25833469
[TBL] [Abstract][Full Text] [Related]
8. When a mid-intronic variation of DMD gene creates an ESE site.
Trabelsi M; Beugnet C; Deburgrave N; Commere V; Orhant L; Leturcq F; Chelly J
Neuromuscul Disord; 2014 Dec; 24(12):1111-7. PubMed ID: 25193336
[TBL] [Abstract][Full Text] [Related]
9. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatic and functional optimization of antisense phosphorodiamidate morpholino oligomers (PMOs) for therapeutic modulation of RNA splicing in muscle.
Popplewell LJ; Graham IR; Malerba A; Dickson G
Methods Mol Biol; 2011; 709():153-78. PubMed ID: 21194027
[TBL] [Abstract][Full Text] [Related]
11. Induced dystrophin exon skipping in human muscle explants.
McClorey G; Fall AM; Moulton HM; Iversen PL; Rasko JE; Ryan M; Fletcher S; Wilton SD
Neuromuscul Disord; 2006 Oct; 16(9-10):583-90. PubMed ID: 16919955
[TBL] [Abstract][Full Text] [Related]
12. Modulation of pre-mRNA splicing in the Duchenne muscular dystrophy gene.
Dunckley MG; Eperon IC; Dickson G
Biochem Soc Trans; 1996 May; 24(2):276S. PubMed ID: 8736934
[No Abstract] [Full Text] [Related]
13. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
[TBL] [Abstract][Full Text] [Related]
14. Splicing intervention for Duchenne muscular dystrophy.
McClorey G; Fletcher S; Wilton S
Curr Opin Pharmacol; 2005 Oct; 5(5):529-34. PubMed ID: 16085461
[TBL] [Abstract][Full Text] [Related]
15. Dysferlin rescue by spliceosome-mediated pre-mRNA trans-splicing targeting introns harbouring weakly defined 3' splice sites.
Philippi S; Lorain S; Beley C; Peccate C; Précigout G; Spuler S; Garcia L
Hum Mol Genet; 2015 Jul; 24(14):4049-60. PubMed ID: 25904108
[TBL] [Abstract][Full Text] [Related]
16. A G-to-A transition at the fifth position of intron-32 of the dystrophin gene inactivates a splice-donor site both in vivo and in vitro.
Thi Tran HT; Takeshima Y; Surono A; Yagi M; Wada H; Matsuo M
Mol Genet Metab; 2005 Jul; 85(3):213-9. PubMed ID: 15979033
[TBL] [Abstract][Full Text] [Related]
17. Identification of a transcriptional enhancer within muscle intron 1 of the human dystrophin gene.
Klamut HJ; Bosnoyan-Collins LO; Worton RG; Ray PN; Davis HL
Hum Mol Genet; 1996 Oct; 5(10):1599-606. PubMed ID: 8894694
[TBL] [Abstract][Full Text] [Related]
18. Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice.
Koo T; Popplewell L; Athanasopoulos T; Dickson G
Hum Gene Ther; 2014 Feb; 25(2):98-108. PubMed ID: 24191945
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscle.
Arechavala-Gomeza V; Graham IR; Popplewell LJ; Adams AM; Aartsma-Rus A; Kinali M; Morgan JE; van Deutekom JC; Wilton SD; Dickson G; Muntoni F
Hum Gene Ther; 2007 Sep; 18(9):798-810. PubMed ID: 17767400
[TBL] [Abstract][Full Text] [Related]
20. Duchenne muscular dystrophy caused by a complex rearrangement between intron 43 of the DMD gene and chromosome 4.
Baskin B; Gibson WT; Ray PN
Neuromuscul Disord; 2011 Mar; 21(3):178-82. PubMed ID: 21134752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
